What's breaking now, across thousands of outlets.
(RTTNews) - Glaukos Corp. (GKOS) on Wednesday reported three-year results from a Phase 3 extension study evaluating Epioxa, its epithelium-on corneal cross-linking therapy for keratoconus.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
British Gas, Eon and Octopus Energy will control the vast majority of the UK's household energy market once the merger completes. Will it be a good thing for customers?
Ethereum co-founder Vitalik Buterin warned that the crypto industry should take risks to cryptography from AI-accelerated math seriously.
Where there’s smoke there’s fire, but is the reverse true? The presumption in California could be that it is. One fallout from the plague of wildfires that struck California in recent years is that…
